Amgen delivers Q4 earnings and revenue beat, driven by strong drug volumes, as attention turns to its late-stage MariTide ...
Centurion Foundation hopes to close on the sale of Roger Williams Medical Center and Fatima Hospital by the end of February ...
Investor's Business Daily on MSN
Amgen hits buy zone on positive 2026 outlook amid sharpening obesity focus
Amgen is running a number of studies of its obesity drug, MariTide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results